Advertisement
Screener

SUPERNUS PHARMACEUTICALS, INC. (SUPN) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

SUPERNUS PHARMACEUTICALS, INC. Cash Flow Breakdown

Cash flow breakdown shows where SUPERNUS PHARMACEUTICALS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $47.33M came in.
  • Fiscal year ended 2025-12-31: from investing, $4.11M came in.
  • Fiscal year ended 2025-12-31: from financing, $9.13M came in.
  • Fiscal year ended 2025-12-31: change in cash, $60.57M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31$47.33M$4.11M-$4.23M$37.62M-$24.26M*$60.57M
2024-12-31$171.95M-$189.87M-$2.71M$14.91M-$5.72M
2023-12-31$111.08M$268.73M-$1.99M$6.61M-$402.50M*-$18.07M
2022-12-31$116.83M-$216.66M$0.00$12.42M-$22.90M*-$110.31M
2021-12-31$127.13M-$81.91M$7.09M-$137.51M*-$85.21M
2020-12-31$138.40M-$34.70M$4.36M-$802.00K*$107.26M
2019-12-31$143.13M-$157.92M$3.93M-$10.87M
2018-12-31$128.99M-$413.48M$11.58M$364.86M*$91.94M
2017-12-31$114.64M-$86.42M$5.68M$33.91M
2016-12-31$66.81M-$35.96M$2.05M$32.90M
2015-12-31$34.52M-$39.29M$1.87M-$2.90M
2014-12-31-$24.50M-$2.66M$571.00K$30.00M*$3.42M
2013-12-31-$57.95M-$12.11M$2.44M$60.30M*-$7.32M
2012-12-31-$47.20M-$48.96M$100.73M-$12.82M*-$8.24M
2011-12-31-$36.19M$33.90M$30.00M$29.00K-$2.94M*$24.80M
2010-12-31-$32.54M$25.82M$4.00K-$948.00K*-$7.67M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$4.81M*$7.09M*-$88.00K*$4.12M*-$11.23M*
2026-03-31$66.52M-$19.22M-$4.55M$13.67M$56.42M
2025-12-31$19.86M*-$51.31M*-$31.00K*$8.56M*
2025-09-30-$61.66M*$48.71M*-$811.00K*$23.74M*-$1.86M*
2025-06-30$58.53M*-$30.61M*-$46.00K*$3.28M*-$2.29M*
2025-03-31$30.60M$37.32M-$3.34M$2.04M-$20.10M*$46.52M
2024-12-31$44.41M*-$12.64M*-$987.00K*$6.88M*
2024-09-30$53.52M*-$77.01M*-$387.00K*$3.46M*
2024-06-30$35.62M*-$48.59M*-$1.00K*$1.66M*
2024-03-31$38.40M-$51.62M-$1.34M$2.91M-$11.65M
2023-12-31$44.96M*-$65.98M*$0.00*$1.09M*
2023-09-30$35.88M*$34.63M*-$970.00K*$740.00K*
2023-06-30-$18.87M*$60.30M*-$575.00K*$2.52M*-$480.86M*
2023-03-31$49.13M$239.78M-$445.00K$2.26M$78.36M*$369.08M
2022-12-31$27.56M*-$48.77M*$2.83M*
2022-09-30$13.84M*-$82.23M*$6.46M*
2022-06-30$71.12M*-$15.68M*$2.27M*
2022-03-31$4.30M-$69.99M$866.00K-$22.90M*-$87.72M
2021-12-31$48.76M*$76.13M*$1.57M*-$138.31M*
2021-09-30-$4.11M*-$5.70M*$524.00K*$800.00K*
2021-06-30$46.27M*-$80.89M*$2.75M*
2021-03-31$36.20M-$71.44M$2.25M-$33.00M
2020-12-31$31.93M*$49.34M*$2.81M*
2020-09-30$5.60M*-$11.30M*$77.00K*-$1.06M*
2020-06-30$91.95M*-$108.18M*$1.44M*
2020-03-31$8.92M$35.44M$32.00K$44.39M
2019-12-31$43.79M*$19.44M*$1.26M*
2019-09-30$37.66M*-$8.36M*$242.00K*
2019-06-30$28.69M*-$65.76M*$1.64M*
2019-03-31$32.99M-$103.25M$783.00K-$69.47M
2018-12-31$32.85M*$34.33M*$1.25M*
2018-09-30$62.45M*$25.34M*$828.00K*
2018-06-30$6.56M*-$422.14M*$6.65M*
2018-03-31$27.13M-$51.01M$2.86M$364.86M*$343.84M
2017-12-31$36.34M*-$19.13M*$1.17M*$18.38M*
2017-09-30$39.01M*-$21.16M*$2.35M*$20.19M*
2017-06-30$25.94M*-$25.36M*$1.56M*$2.14M*
2017-03-31$13.36M-$20.76M$604.00K-$6.80M
2016-12-31$24.94M*-$13.64M*$797.00K*$12.09M*
2016-09-30$28.24M*-$10.35M*$260.00K*$18.15M*
2016-06-30$16.78M*-$1.32M*$871.00K*$16.33M*
2016-03-31-$3.14M-$10.65M$124.00K-$13.67M
2015-12-31$19.93M*-$12.87M*$800.00K*$7.86M*
2015-09-30-$575.00K*-$6.95M*$58.00K*-$6.82M*
2015-06-30$14.67M*-$8.23M*$862.00K*$7.30M*
2015-03-31$503.00K-$11.24M$147.00K-$11.24M
2014-12-31$6.26M*-$7.95M*$306.00K*-$1.38M*
2014-09-30-$4.71M*$524.00K*$14.00K*$30.00M*$25.82M*
2014-06-30-$6.94M*$6.40M*$245.00K*-$296.00K*
2014-03-31-$19.10M-$1.63M$6.00K-$20.73M
2013-12-31-$9.42M*$20.91M*$273.00K*-$1.73M*$10.04M*
2013-09-30-$15.55M*$4.61M*$11.00K*-$10.96M*
2013-06-30-$15.76M*-$34.48M*$217.00K*$65.02M*$15.00M*
2013-03-31-$17.22M-$3.15M$1.94M-$2.96M*-$21.39M
2012-12-31-$16.14M*-$9.35M*$48.29M*-$5.91M*$16.89M*
2012-09-30-$11.30M*-$10.30M*$39.00K*-$2.26M*-$23.83M*
2012-06-30-$9.69M*-$7.76M*$52.36M*-$3.54M*$31.38M*
2012-03-31-$10.07M-$21.55M$49.00K-$1.11M*-$32.68M
2011-12-31-$8.26M*$25.43M*$28.00K*$14.86M*$32.06M*
2011-09-30-$9.10M*$10.34M*$0.00*-$1.32M*-$77.00K*
2011-06-30-$9.02M*$3.83M*$912.00K*-$4.28M*
2011-03-31-$9.80M-$5.70M$12.61M*-$2.90M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38